Funding Rounds
Immatics funding round, October 2017
Immatics BiotechnologiesImmatics Biotechnologies is a biopharmaceutical company focused on the discovery and development of immunotherapy of cancer.
Summary
Stage: Series E
Raised Amount: $58.00M
Raised Date: 2017-10-01
